Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study
Marina Talamonti(NorthShore University HealthSystem), Angelo Valerio Marzano(University of Milan), M. Lombardo(Ospedale di Circolo e Fondazione Macchi), Francesco Loconsole(University of Bari Aldo Moro), Andrea Chiricozzi(Università Cattolica del Sacro Cuore), Claudio Feliciani(University of Parma), Mariateresa Rossi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Annamaria Offidani(Marche Polytechnic University), Gabriella Fabbrocini(Universitätsklinik für Chirurgie Wien), Stefano Piaserico(University of Padua), Andrea Conti(Policlinico di Modena), Paola Savoia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Luca Stingeni(University of Perugia), Paolo D. Pigatto(University of Milan), Serafinella Patrizia Cannavò(University of Messina), Paolo Amerio(Sunnybrook Health Science Centre), Marco Galluzzo(University of Rome Tor Vergata), Maria Concetta Fargnoli(University of L'Aquila), Concetta Potenza(Danieli (Italy)), Maria Rita Bongiorno(University of Palermo), Federico Bardazzi(University of Bologna), Pietro Quaglino(Department of Medical Sciences), Giuseppe Argenziano(Regione Campania), Andrea Carugno(University of Insubria), Pietro Rubegni(University of Siena), Steven Paul Nisticò(Sapienza University of Rome), Giuseppe Micali(University of Catania), Francesca Prignano(University of Florence), Sandra Giustini(Sapienza University of Rome), Iris Zalaudek(Azienda Sanitaria Universitaria Integrata di Trieste), Paolo Gisondi(University of Verona), Franco Rongioletti(Vita-Salute San Raffaele University), Aurora Parodi(Ospedale Policlinico San Martino), Ketty Peris(Università Cattolica del Sacro Cuore), Luca Bianchi(University of Rome Tor Vergata), Giulia Rech(Ospedale Santa Chiara)
Cited by 43
Related Papers
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
|Clinical Reviews in Allergy & Immunology|2018|738
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555